Glucagon in therapy
Rathery, M.
Journees Annuelles de Diabetologie de l'Hotel-Dieu 13: 119-123
1972
ISSN/ISBN: 0075-4439 PMID: 4605686 Document Number: 56953
Document emailed within 1 workday
Related Documents
Tanjoh, K.; Tomita, R.; Hayashi, N. 2002: The peculiar processing of glucagon and glucagon-related peptides in patients after pancreatectomy Hepato-Gastroenterology 49(45): 825-832Kiil, J.; Andersen, D.; Weinreich, J. 1977: Antrum relaxation during endoscopy. a comparison between butylscopolammonium bromide (Buscopan) and glucagon chloride (Glucagon Novo) Ugeskrift for Laeger 139(20): 1176-1177
Artese, D.; Di Nicola, A.; Santilli, S. 1976: Use of glucagon in the therapy of cardiac insufficiency Minerva Cardioangiologica 24(2): 155-160
Shomali, M.E. 2009: Practical applications of therapy with a glucagon-like peptide-1 receptor agonist Journal of Family Practice 58(9 Suppl Treating): S35-S43
Wei, P.; Yang, Y.; Li, T.; Ding, Q.; Sun, H. 2015: A engineered Bifidobacterium longum secreting a bioative penetratin-Glucagon-like peptide 1 fusion protein enhances Glucagon-like peptide 1 absorption in the intestine Journal of Microbiology and Biotechnology 2015
Holst, J.J.; Schwartz, T.W.; Lovgreen, N.A.; Pedersen, O.; Beck-Nielsen, H. 1983: Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity International Journal of Obesity 7(6): 529-538
Urdahl, P.; Jørgensen, H.S. 1986: Glucagon-stimulated plasma c-peptide in diabetics. Clinical parameters in the choice of therapy? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(16): 1392-1395
Marugo, M.; Mortara, R.; Baiardi, M.; Giusti, M.; Motta, A.; Grimaldi, G.P. 1981: Evaluation of the metabolic action of glucagon in subjects undergoing anti-insulin therapy La Clinica Terapeutica 96(6): 579-592
Shubrook, J.H. 2018: Advances in Type 2 Diabetes: Focus on Basal Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy Journal of Family Practice 67(8 Suppl): S49-S54
Korányi, L.; Tamás, G.; Gerö, L.; Halmos, T.; Baranyai, E.; Büki, B. 1981: Glucagon antibodies in the blood of insulin-treated diabetics (effect of monospecific and monocomponent insulin therapy on antibody level) Orvosi Hetilap 122(23): 1371-1374
Tarnawski, A. 1980: Effect of gastrointestinal hormones on gastric mucosa with special regard to the regulation of its electric potential. IV. Studies on the appearance of immunoreactive glucagon in human gastric juice. Effect of pentagastrin on glucagon concentration in the gastric juice of healthy persons and patients with duodenal ulcer Folia Medica Cracoviensia 22(1): 93-110
Matsuyama, T.; Kuwajima, M. 1997: Glucagon, GLP Nihon Rinsho. Japanese Journal of Clinical Medicine 55 Suppl: 133-141
Whalen, G.E. 1974: Glucagon and the small gut Gastroenterology 67(6): 1284-1286
Goldinger, G.; Aeberhard, P. 1980: The glucagon syndrome Helvetica Chirurgica Acta 47(1-2): 199-204
Kalra, S.; Dhingra, M. 2019: Intranasal Glucagon Jpma. Journal of the Pakistan Medical Association 69(8): 1219-1221
Fallucca, G.; Colletti, A.; Maestripieri, P.L.; Mirabella, C.; Andreani, D. 1977: Glucagon in prediabetes Panminerva Medica 19(2): 95-100
Krimphove, M.; Opitz, K. 1975: The calorigenic effect of glucagon Archives Internationales de Pharmacodynamie et de Therapie 216(2): 328-350
Graner, J.L.; Abraira, C. 1985: Glucagon in the cerebrospinal fluid New England Journal of Medicine 312(15): 994-995
Dekoninck, W.J. 1970: Glucagon and cardiac decompensation Bruxelles Medical 50(5): 375-376
Kawabe, K.; Ito, T. 2005: Pancreatic glucagon (IRG), enteroglucagon (EG) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 493-495